Skip to main content
. 2015 Nov 6;16(11):26608–26618. doi: 10.3390/ijms161125981

Figure 3.

Figure 3

Cx50 expression in healthy spinal cord tissue, after SCI, and epSPCi transplantation. Immunohistochemical evaluation of Cx50 and the astrocytic marker GFAP in tissues from (A) non-injured spinal cord and 2 months after SCI (Zoom; Cx50/GFAP/DAPI); Scale bar = 25 µm, and (B) 2 months after SCI with GFP-epSPCi transplantation (Zoom; epSPCi/TuJ1/Cx50); * epicenter of the injury area.